Douglas R. Morton
- Physiology top 5%
- Pharmacology top 2%
- Molecular Biology
- Organic Chemistry top 5%
- Biochemistry top 1%
- Co-authors
- Robert R. GormanM K BachZvi MaromMichael KalinerJames H. ShelhamerJames C. McGuireRoy A. JohnsonJohn H. Kinner
- Topics
- Inflammatory mediators and NSAID effects (9 papers)Oxidative Organic Chemistry Reactions (5 papers)Asthma and respiratory diseases (5 papers)
- Cited by
- BiochemistryPharmacologyPhysiology
- Journals
- Journal of the American Chemical SocietyJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Douglas R. Morton
40 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Physiology 655
- Pharmacology 575
- Molecular Biology 465
- Organic Chemistry 421
- Biochemistry 345
Countries citing papers authored by Douglas R. Morton
This map shows the geographic impact of Douglas R. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Morton more than expected).
Fields of papers citing papers by Douglas R. Morton
This network shows the impact of papers produced by Douglas R. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Morton. The network helps show where Douglas R. Morton may publish in the future.
Co-authorship network of co-authors of Douglas R. Morton
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Morton. A scholar is included among the top collaborators of Douglas R. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Morton. Douglas R. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | Inhibition of rat liver glutathione S-transferases by piriprost: kinetics of the inhibition and preliminary evidence that piriprost may be a poor alternative substrate for these enzymes. | 6 |
| 3 | Chemistry of the prostaglandins and leukotrienes | 4 |
| 4 | 84 | |
| 5 | 119 | |
| 6 | 15 | |
| 7 | 12 | |
| 8 | 17 | |
| 9 | Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro.breakdown → | 358 |
| 10 | 144 | |
| 11 | 7 | |
| 12 | 9 | |
| 13 | 18 | |
| 14 | 9 | |
| 15 | 6 | |
| 16 | 34 | |
| 17 | 19 | |
| 18 | 7 | |
| 19 | 6 | |
| 20 | 3 |
About Douglas R. Morton
Douglas R. Morton is a scholar working on Pharmaceutical Science, Organic Chemistry and Pharmacology, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Oxidative Organic Chemistry Reactions (5 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Biochemistry (345 citations), Pharmacology (575 citations) and Physiology (655 citations). Douglas R. Morton has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Robert R. Gorman, M K Bach, Zvi Marom, Michael Kaliner, James H. Shelhamer, James C. McGuire, Roy A. Johnson, John H. Kinner, Norman Whittaker and John R. Vane. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.